Education
About Us
Working with TipRanks
Follow Us
Erika Carmel Ltd. (IL:BCUR)
:BCUR
Total Valuation
Erika B-Cure has a market cap or net worth of 22.29M. The enterprise value is 714.48M.
Market Cap22.29M
Enterprise Value714.48M
Share Statistics
Erika B-Cure has 104,165,290 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding104,165,290
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Erika B-Cure’s return on equity (ROE) is -0.63 and return on invested capital (ROIC) is -46.49%.
Return on Equity (ROE)-0.63
Return on Assets (ROA)-0.27
Return on Invested Capital (ROIC)-46.49%
Return on Capital Employed (ROCE)-0.56
Revenue Per Employee949.02K
Profits Per Employee-236.75K
Employee Count40
Asset Turnover1.09
Inventory Turnover0.73
Valuation Ratios
The current PE Ratio of Erika B-Cure is -2.56. Erika B-Cure’s PEG ratio is -38.86.
PE Ratio-2.56
PS Ratio0.00
PB Ratio227.24
Price to Fair Value1.61
Price to FCF143.89
Price to Operating Cash Flow125.01
PEG Ratio-38.86
Income Statement
In the last 12 months, Erika B-Cure had revenue of 37.96M and earned -9.47M in profits. Earnings per share was -0.09.
Revenue37.96M
Gross Profit26.05M
Operating Income-9.93M
Pretax Income-10.51M
Net Income-9.47M
EBITDA-8.30M
Earnings Per Share (EPS)-0.09
Cash Flow
In the last 12 months, operating cash flow was -4.22M and capital expenditures -94.00K, giving a free cash flow of -4.32M billion.
Operating Cash Flow-4.22M
Free Cash Flow-4.32M
Free Cash Flow per Share-0.04
Dividends & Yields
Erika B-Cure pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.60
52-Week Price Change-28.43%
50-Day Moving Average21.09
200-Day Moving Average22.78
Relative Strength Index (RSI)50.77
Average Volume (3m)87.00K
Important Dates
Erika B-Cure upcoming earnings date is Aug 31, 2021, TBA (Confirmed).
Last Earnings DateInvalid Date
Next Earnings DateAug 31, 2021
Ex-Dividend Date―
Financial Position
Erika B-Cure as a current ratio of 1.64, with Debt / Equity ratio of 452.46%
Current Ratio1.64
Quick Ratio0.66
Debt to Market Cap<0.01
Net Debt to EBITDA-0.16
Interest Coverage Ratio-39.08
Taxes
In the past 12 months, Erika B-Cure has paid -1.04M in taxes.
Income Tax-1.04M
Effective Tax Rate0.10
Enterprise Valuation
Erika B-Cure EV to EBITDA ratio is -3.08, with an EV/FCF ratio of -5.92.
EV to Sales0.67
EV to EBITDA-3.08
EV to Free Cash Flow-5.92
EV to Operating Cash Flow-6.05
Balance Sheet
Erika B-Cure has 4.15M in cash and marketable securities with 3.09M in debt, giving a net cash position of -1.05M billion.
Cash & Marketable Securities4.15M
Total Debt3.09M
Net Cash-1.05M
Net Cash Per Share-0.01
Tangible Book Value Per Share0.14
Margins
Gross margin is 88.17%, with operating margin of -26.15%, and net profit margin of -24.95%.
Gross Margin88.17%
Operating Margin-26.15%
Pretax Margin-27.70%
Net Profit Margin-24.95%
EBITDA Margin-21.86%
EBIT Margin-27.03%
Analyst Forecast
The average price target for Erika B-Cure is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―